On September 22, the Senate Health, Education, Labor, and Pensions Committee held a hearing, “Exploring Current Practices in Cosmetic Development and Safety.” The hearing focused on understanding how cosmetic products are developed, reviewed, and determined to be safe for public use. In addition, the committee explored whether the Food and Drug Administration has the tools necessary to protect the public health.
The following witnesses testified: